Melanoma (Issue 2) | Special Reports

Sequencing Strategies in Treating Patients With Melanoma

April 17, 2014

Clinical Articles

Michael A. Postow, MD, attending physician, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, discusses sequencing strategies in treating patients with melanoma.

An Overview of Immune Checkpoint Blockade

April 16, 2014

Clinical Articles

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Lloyd J. Old Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center, explains immune checkpoint blockade.

Approaches to Sequencing in Melanoma: Three Melanoma Specialists Weigh In

April 16, 2014

Clinical Articles

Melanoma experts and researchers have gained ground in the development of novel and effective immunotherapies as well as targeted agents for those patients with metastatic melanoma who harbor specific tumor mutations.

What’s Next With Next-Generation BRAF Inhibitors?

April 15, 2014

Clinical Articles

Targeted therapy for patients with activating BRAF mutations has demonstrated the potential for personalized medicine in patients with metastatic melanoma. Initial study results were promising and dramatic.